1. Home
  2. GDRX vs KARD Comparison

GDRX vs KARD Comparison

Compare GDRX & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$3.60

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

HOLD

Current Price

$12.63

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDRX
KARD
Founded
2011
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
GDRX
KARD
Price
$3.60
$12.63
Analyst Decision
Hold
Strong Buy
Analyst Count
14
6
Target Price
$3.95
★ $38.67
AVG Volume (30 Days)
★ 878.1K
609.2K
Earning Date
11-03-2026
11-22-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.00
N/A
EPS
★ 0.03
N/A
Revenue
★ $796,853,000.00
N/A
Revenue This Year
$0.20
N/A
Revenue Next Year
$4.72
$50.00
P/E Ratio
$119.33
★ N/A
Revenue Growth
★ 0.57
N/A
52 Week Low
$1.77
$12.23
52 Week High
$4.05
$27.00

Technical Indicators

Market Signals
Indicator
GDRX
KARD
Relative Strength Index (RSI) 60.70 35.12
Support Level $3.26 $12.23
Resistance Level $3.89 $15.93
Average True Range (ATR) 0.12 1.36
MACD 0.03 0.08
Stochastic Oscillator 91.46 10.95

Price Performance

Historical Comparison
GDRX
KARD

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: